Lessons From The 1st Biopharma Inter Partes Reviews
Recently, the Patent Trial and Appeal Board issued its first set of final written decisions in three inter partes reviews relating to molecules in the large molecule biopharma space (IPR2013-00534, IPR2013-00535 and...To view the full article, register now.
Already a subscriber? Click here to view full article